Phio holders approve 1.5M-share increase to 2020 incentive plan; all six directors elected

Phio Pharmaceuticals Corp.

Stockholders approved Amendment No. 1 raising shares issuable under the 2020 Long Term Incentive Plan by 1,500,000, to a total of 2,452,017 shares.
Plan amendment passed with 1,155,945 votes for, 194,070 against, 34,468 abstained and 3,823,097 broker non-votes.
All six directors elected to serve until the 2027 annual meeting; Robert J. Bitterman received 1,341,217 for and 43,266 withheld.
Grant Thornton LLP ratified as independent auditor for fiscal 2026 by 5,087,608 for to 88,779 against; 31,193 abstained.
11,617,250 shares were outstanding as of the August 4, 2026 record date; 5,207,580 shares were represented at the September 28, 2026 meeting.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.